Detalhe da pesquisa
1.
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Am J Hematol;
99(3): 494-496, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38240336
2.
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Haematologica;
108(11): 3025-3032, 2023 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37102592
3.
Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.
Am J Hematol;
98(7): E172-E174, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37078687
4.
Impact of academic medical center access on outcomes in multiple myeloma.
Am J Hematol;
98(1): 41-48, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36266759
5.
Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy.
Clin Lymphoma Myeloma Leuk;
24(2): 94-104.e6, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38000981
6.
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.
EJHaem;
3(3): 930-935, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36051026
7.
Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis.
Clin Lymphoma Myeloma Leuk;
20(4): e174-e183, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32067954
8.
Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate.
Fed Pract;
36(Suppl 1): S30-S33, 2019 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30867634
9.
Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.
Cureus;
11(2): e4088, 2019 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31057992